Swiss MedTech Start-up about to Launch in Foreign Markets
Zurich, 7 March 2022 -The MedTech start-up Sleepiz has successfully completed the second closing of its Series A financing round. The company raised a further 1.8 million Swiss francs, bringing the total investment to 6.2 million Swiss francs. The fresh capital will primarily be used to launch the sleep apnoea monitor in foreign markets. establishing and growing our presence in the United States.”
11. September 2022
Sleepiz launches contactless device for remote patient monitoring in the United States; appoints Robb LaChappelle as VP for the US
FDA listing paves the way for Sleepiz’ entry into the U.S. market and enables contactless, in-home respiration and heart rate measurement for remote patient monitoring and innovative medical study design.
10. September 2022